PhenixFIN Corporation

NasdaqGM:PFX Rapport sur les actions

Capitalisation boursière : US$95.4m

PhenixFIN Croissance future

Future contrôle des critères 1/6

PhenixFIN's earnings are forecast to decline at 67.9% per annum while its annual revenue is expected to grow at 11.9% per year. EPS is expected to decline by 67% per annum.

Informations clés

-67.9%

Taux de croissance des bénéfices

-67.0%

Taux de croissance du BPA

Capital Markets croissance des bénéfices14.3%
Taux de croissance des recettes11.9%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour12 Aug 2024

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

PhenixFIN GAAP NII of $0.09, total investment income of $3.7M beats by $0.15M

Aug 10

If You Had Bought PhenixFIN's (NASDAQ:PFX) Shares Five Years Ago You Would Be Down 77%

Jan 14
If You Had Bought PhenixFIN's (NASDAQ:PFX) Shares Five Years Ago You Would Be Down 77%

PhenixFin, formerly Medley Capital, adopts $15M stock buyback program

Jan 11

Medley Capital transfers listing from NYSE to NASDAQ

Dec 22

Medley Capital net investment loss shrinks, NAV rises in fiscal Q4

Dec 11

Prévisions de croissance des bénéfices et des revenus

NasdaqGM:PFX - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
9/30/2025267N/AN/A1
9/30/20242415N/AN/A1
6/30/2024222033N/A
3/31/2024212666N/A
12/31/20232128-9-9N/A
9/30/20232027-21-21N/A
6/30/20232015-14-14N/A
3/31/202318-3-22-22N/A
12/31/202217-7-24-24N/A
9/30/202216-6-29-29N/A
6/30/202215-8-9-9N/A
3/31/2022208-1-1N/A
12/31/2021231355N/A
9/30/20213219595N/A
6/30/202132107777N/A
3/31/202128109494N/A
12/31/202027-76111111N/A
9/30/202022-667878N/A
6/30/202025-99124124N/A
3/31/202032-137223223N/A
12/31/201940-82221221N/A
9/30/201946-97180180N/A
6/30/201953-888383N/A
3/31/201956-856767N/A
12/31/201860-89113113N/A
9/30/201867-1117979N/A
6/30/201874-100155155N/A
3/31/201884-70N/A111N/A
12/31/201791-53N/A31N/A
9/30/201796-15N/A66N/A
6/30/2017101-6N/A158N/A
3/31/20171065N/A120N/A
12/31/201611218N/A216N/A
9/30/2016121-28N/A273N/A
6/30/2016130-41N/A129N/A
3/31/2016138-47N/A135N/A
12/31/2015144-36N/A84N/A
9/30/2015149-15N/A-21N/A
6/30/201515111N/A-150N/A
3/31/201515319N/A-234N/A
12/31/201414820N/A-388N/A
9/30/201413952N/A-400N/A
6/30/201412958N/A-304N/A
3/31/201411445N/A-350N/A
12/31/201310344N/A-251N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: PFX's earnings are forecast to decline over the next 3 years (-67.9% per year).

Bénéfices vs marché: PFX's earnings are forecast to decline over the next 3 years (-67.9% per year).

Croissance élevée des bénéfices: PFX's earnings are forecast to decline over the next 3 years.

Chiffre d'affaires vs marché: PFX's revenue (11.9% per year) is forecast to grow faster than the US market (8.9% per year).

Croissance élevée des revenus: PFX's revenue (11.9% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if PFX's Return on Equity is forecast to be high in 3 years time

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y